Phase 1 dose escalation study of SL-172154 (SIRPa-Fc-CD40L) in platinum-resistant ovarian cancer.
SL-172154
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 1 dose escalation study of SL-172154 (SIRPa-Fc-CD40L) in platinum-resistant ovarian cancer. ### Output: SL-172154